Center for Scientific Review; Notice of Closed Meetings, 49878-49879 [E9-23336]
Download as PDF
<![CDATA[
49878
Federal Register / Vol. 74, No. 187 / Tuesday, September 29, 2009 / Notices
October 1, 1995, unless it displays a
currently valid OMB control number.
5 CFR 1320.5: Reporting and
Recordkeeping Requirements: Final
Rule: Respondents to this collection of
information are not required to respond
unless the data collection instruments
display a currently valid OMB control
number.
Proposed Collection: Title: The Sister
Study PHASE 2: Environmental and
Genetic Risk Factors for Breast Cancer.
Type of Information Collection Request:
Revision of OMB No. 0925–0522 and
expiration date 30 September 2009.
Need and Use of Information Collection:
The purpose of the Sister Study is to
study genetic and environmental risk
factors for the development of breast
cancer in a high-risk cohort of sisters of
women who have had breast cancer. In
the United States, approximately
192,370 new cases of invasive breast
cancer are anticipated in 2009. The
etiology of breast cancer is complex,
with both genetic and environmental
factors likely playing a role.
Environmental risk factors, however,
have been difficult to identify. By
focusing on genetically susceptible
subgroups, more precise estimates of the
contribution of environmental and other
non-genetic factors to disease risk may
be possible. Sisters of women with
breast cancer are one group at increased
risk for breast cancer; we would expect
at least 2 times as many breast cancers
to accrue in a cohort of sisters as would
accrue in a cohort identified through
random sampling or other means. In
addition, a cohort of sisters should be
enriched with regard to the prevalence
of relevant genes and/or exposures,
further enhancing the ability to detect
gene-environment interactions. Sisters
of women with breast cancer will also
be at increased risk for ovarian cancer
and possibly for other hormonallymediated diseases. We have enrolled a
cohort of 50,000 women who have not
had breast cancer. Recruitment took
place from August 2003 through July
2009. We estimate that in the cohort of
50,000 sisters, aged 35–74 at enrollment,
approximately 300 new cases of breast
Estimated
number of
respondents
Activity (3-yrs)
cancer will be diagnosed during each
year of follow-up. Frequency of
Response: For the remainder of the
study, women will be contacted once
each year to update contact information
and health status (5–10 minutes per
response); and asked to complete short
(60–75 minutes, total) updates every
two-to-three years. Women diagnosed
with breast cancer or other health
outcomes of interest are asked to
provide additional information about
their diagnosis (20 minutes per
response) and their doctors will be
contacted to provide medical records
related to diagnosis and treatments (15
minutes per response). Affected Public:
Study participants; medical office staff.
Type of Respondents: Participants
enrolled in high-risk cohort study of risk
factors for breast cancer. The annual
reporting burden is as follows:
Estimated Number of Respondents:
50,000 study participants and 2100
medical office staff. Estimated Number
of Responses per Respondent: See table
below:
Estimated
responses per
respondent
Average
burden hours
per response
Estimated total
burden hours
requested
50,000
50,000
1800
300
2100
2
1
1
1
1
0.085
1.25
0.33
0.33
0.25
8,500
62,500
594
99
525
Total ..........................................................................................................
jlentini on DSKJ8SOYB1PROD with NOTICES
Annual Updates ...............................................................................................
Bi/Trienniel Follow-Up ......................................................................................
Incident BC Case Follow-Up ...........................................................................
Incident Other Case Follow-Up .......................................................................
Incident Case Medical Office Contact .............................................................
........................
........................
........................
72,218
Average Burden Hours Per Response:
0.7 hour; and Estimated Total Burden
Hours Requested: 72,218 (over 3 years).
The average annual burden hours
requested is 24,073. The annualized cost
to respondents is estimated at $14
(assuming $20 hourly wage × 0.7 hour).
There are no Capital Costs to report.
There are no Operating or Maintenance
Costs to report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
VerDate Nov<24>2008
16:18 Sep 28, 2009
Jkt 217001
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr. Dale
P. Sandler, Chief, Epidemiology Branch,
NIEHS, Rall Building A3–05, PO Box
12233, Research Triangle Park, NC
27709 or call non-toll-free number (919)
541–4668 or E-mail your request,
including your address to:
‘‘sandler@niehs.nih.gov.’’
Comments Due Date: Comments
regarding this information collection are
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: September 22, 2009.
Marc Hollander,
NIEHS, Associate Director for Management.
[FR Doc. E9–23510 Filed 9–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\29SEN1.SGM
29SEN1
Federal Register / Vol. 74, No. 187 / Tuesday, September 29, 2009 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Immunology
Integrated Review Group, Innate Immunity
and Inflammation Study Section.
Date: October 15–16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Key Bridge Marriott, 1401 Lee
Highway, Arlington, VA 22209.
Contact Person: Tina McIntyre, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
6375, mcintyrt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict.
Date: October 15, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Jose Fernando Arena, PhD,
MD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–435–
1735, arenaj@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Microcirculation, Hypertension and
Atherosclerosis.
Date: October 20–21, 2009.
Time: 11 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Anshumali Chaudhari,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124,
MSC 7802, Bethesda, MD 20892, (301) 435–
1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Investigations on Primary Immunodeficiency
Diseases.
Date: October 20, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Jin Huang, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4095G, MSC 7812, Bethesda,
MD 20892, 301–435–1230, jh377p@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Eukaryotic
Pathogens and Their Vectors.
VerDate Nov<24>2008
16:18 Sep 28, 2009
Jkt 217001
Date: October 20, 2009.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Richard G. Kostriken, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC, 7808 Bethesda, MD 20892, 301–402–
4454, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PARO8–
224: System Dynamics Methodologies.
Date: October 26, 2009.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Fungai Chanetsa, MPH,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135,
MSC 7770, Bethesda, MD 20892, 301–435–
1262, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Cell Death and Neurodegeneration.
Date: October 26, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Alexander Yakovlev, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, 301–435–
1254, yakovleva@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–23336 Filed 9–28–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
49879
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Reproductive Sciences and Development.
Date: October 14–15, 2009.
Time: 10 a.m. to 1 p.m.
Agenda: To review and evaluate grant
Applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Krish Krishnan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, (301) 435–
1041, krishnak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Mental
Health and Neurodegenerative Disorders
Members. Conflict.
Date: October 26–27, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Suzan Nadi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 521 7B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Hepatobiliary Pathophysiology,
Toxicology and Pharmacology.
Date: October 26–27, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
Applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Bonnie L. Burgess-Beusse,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Ethical,
Legal and Societal Implications of Genetics.
Date: October 29, 2009.
Time: 2 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
Applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Diane L. Stassi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2200,
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 74, Number 187 (Tuesday, September 29, 2009)]
[Notices]
[Pages 49878-49879]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23336]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose
[[Page 49879]]
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Immunology Integrated Review Group, Innate
Immunity and Inflammation Study Section.
Date: October 15-16, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA
22209.
Contact Person: Tina McIntyre, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892, 301-594-
6375, mcintyrt@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict.
Date: October 15, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Jose Fernando Arena, PhD, MD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-435-1735, arenaj@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Microcirculation, Hypertension and Atherosclerosis.
Date: October 20-21, 2009.
Time: 11 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Anshumali Chaudhari, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD
20892, (301) 435-1210, chaudhaa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Investigations on Primary Immunodeficiency Diseases.
Date: October 20, 2009.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Jin Huang, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4095G, MSC 7812, Bethesda, MD 20892, 301-435-
1230, jh377p@nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Eukaryotic Pathogens and Their Vectors.
Date: October 20, 2009.
Time: 3:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Richard G. Kostriken, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC, 7808 Bethesda, MD
20892, 301-402-4454, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, PARO8-224: System Dynamics Methodologies.
Date: October 26, 2009.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Fungai Chanetsa, MPH, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD
20892, 301-435-1262, fungai.chanetsa@nih.hhs.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Cell Death and Neurodegeneration.
Date: October 26, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Alexander Yakovlev, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD
20892, 301-435-1254, yakovleva@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 22, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23336 Filed 9-28-09; 8:45 am]
BILLING CODE 4140-01-M
